This content is machine translated Conference on Retroviruses and Opportunistic Infections (CROI 2022) Five-year data of single-tablet regimen B/F/TAF published. At the 29th CROI, Gilead Sciences presented five-year data from two Phase 3 studies (Study 1489 and Study 1490) that evaluated use in untreated individuals living with HIV. The results…
View Post 6 min This content is machine translated Management of rheumatoid arthritis “Anyone diagnosed with RA today wants to be completely symptom-free.” With the development of conventional, biologic, and targeted disease-modifying antirheumatic drugs, the prognosis for rheumatoid arthritis has improved significantly since the 1990s. However, many patients still do not respond to…
View Post 6 min This content is machine translated Valérie Krafft, Executive Director of the Rheumatism League Switzerland: “Rheumatic diseases still meet with a lot of misunderstanding from the public” The Swiss Rheumatism League has been working for people with rheumatism since 1958. In an interview, Executive Director Valérie Krafft explains how the non-profit organization supports those affected, why the…
View Post 5 min This content is machine translated Virtual workshops for women with breast cancer “Sometimes it just takes the right start to make a positive change.” Breast cancer patients often face stress, anxiety and physical discomfort. The “I do it for me!” workshops are designed to enable those affected to meet these challenges. Dr. Sonja Ebner…
View Post 5 min This content is machine translated Focal spasticities “An enormous relief in daily practice”. Botulinum toxins are increasingly used in the treatment of spasticity, but so far different preparations have been used depending on the etiology and localization [1]. A new preparation can now…
View Post 5 min This content is machine translated Interview with Prof. Dr. med. Pascal Richette Facing the challenges of psoriatic arthritis management Despite remarkable progress in the treatment of patients with psoriatic arthritis (PsA), the management of this chronic disease still poses major challenges [1]. In the following interview, Prof. Pascal Richette,…
View Post 2 min This content is machine translated Forecast improvement within reach Successful HFpEF therapy for the first time Prof. Stefan Anker, MD, provides a summary overview of the key outcomes of the EMPEROR-Preserved study.
View Post 4 min This content is machine translated Moderate to severe atopic dermatitis Modern system therapies “revisited” – advantages and disadvantages in clinical practice In an interview with DERMATOLOGIE PRAXIS, PD Dr. Dr. med. Ahmad Jalili, specialist in dermatology and venereology at the Dermatology & Skin Care Clinic and president of DermaNet Switzerland, talks…
View Post 3 min This content is machine translated European Lung Cancer Congress 2021 “Thoracic tumors remain unpredictable and dangerous” This year’s European Lung Cancer Congress (ELCC) was all about lung cancer. Prof. Oliver Gautschi, MD, Co-Chief Physician of the Clinic for Medical Oncology at the Lucerne Cantonal Hospital (LUKS),…
View Post 12 min This content is machine translated Interview: Prof. Dr. med. Dr. sc. nat. Heinz Läubli Promoting collaboration – at all levels Recently, Prof. Dr. Dr. Heinz Läubli, Head Physician for Oncology at the University Hospital Basel, received this year’s Annemarie Karrasch Research Award of the Basel Research Foundation propatient. Läubli’s research…
View Post 6 min This content is machine translated A reportage from life The doctor as patient Dealing with often serious illness is the most central element of the medical profession. Their own vulnerability is usually in the background. But what if it hits you? How does…
